TXG 10x Genomics, Inc.: institutional ownership and insider trading
431 funds reported holding $5.21B of 10x Genomics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $118M, with 94 new positions and 34 funds selling out; over the last 12 months insiders bought $0 and sold $16.9M on the open market; over its last four quarters it reported revenue of $617M and net income of −$75.1M.
TXG revenue and earnings
- Quarter ended Jun 30, 2026: revenue $151M, net income −$17.9M, EPS -0.14
- Quarter ended Mar 31, 2026: revenue $151M, net income −$13.5M, EPS -0.10
- Quarter ended Dec 31, 2025: revenue $166M, net income −$16.2M, EPS -0.13
- Quarter ended Sep 30, 2025: revenue $149M, net income −$27.5M, EPS -0.22
Famous investors holding TXG
- Cathie Wood (ARK Investment Management): $384M, 2.5% of the portfolio
- Stanley Druckenmiller (Duquesne Family Office): $15.5M, 0.3% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $30.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $114M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $8.94M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $5.44M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $4.48M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $513K, 0.0% of the portfolio
Largest institutional holders of TXG
- FMR LLC — $676M
- BlackRock, Inc. (BLK) — $414M
- ARK Investment Management LLC — $384M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $268M
- VANGUARD GROUP INC — $212M
- Quantinno Capital Management LP — $210M
- VANGUARD CAPITAL MANAGEMENT LLC — $195M
- PRICE T ROWE ASSOCIATES INC /MD/ — $174M
- Sumitomo Mitsui Trust Group, Inc. — $161M
- Amova Asset Management Americas, Inc. — $161M
Recent TXG insider trades
- Sep 22, 2026: Saxonov Serge sold 25,000 shares ($2.03M)
- Sep 22, 2026: Suliman Shehnaaz sold 5,723 shares ($465K)
- Sep 9, 2026: Taich Adam sold 46,388 shares ($3.00M)
- Sep 3, 2026: Stuelpnagel John R sold 20,000 shares ($1.24M)
5%+ owners
- T. Rowe Price Associates, Inc.: 11.7% (Schedule 13G, filed Sep 8, 2026)
- Vanguard Portfolio Management: 5.9% (Schedule 13G, filed Apr 28, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Apr 29, 2026)
- ARK Investment Management LLC: 5.2% (Schedule 13G/A, filed Oct 7, 2026)